Walgreens Boots Alliance Inc. abandoned the sale of its Boots drugstore chain that was expected to bring more than $6 billion after failing to secure the desired valuation for the U.K. business amid a turbulent credit market.
To read the entire story, you must be logged in.
Please log in now or register with us.
